Prevalence and cognitive impact of medial temporal atrophy in a hospital stroke service: Retrospective cohort study

International Journal of Stroke

Volumn 10, Issue 6, 2015, Pages 861-867

  Kebets, Valeria ^a   Gregoire, Simone M ^a   Charidimou, Andreas ^a   Barnes, Josephine ^b   Rantell, Khadija ^a   Brown, Martin M ^a   Jäger, Hans R ^a   Cipolotti, Lisa ^c   Werring, David J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cerebral amyloid angiopathy; Medial temporal lobe atrophy

Indexed keywords

ADOLESCENT; ADULT; AGE; ALZHEIMER DISEASE; ARTICLE; ATTENTION; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COGNITION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; HOSPITAL SERVICE; HUMAN; INTELLIGENCE QUOTIENT; LACUNE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE ATROPHY; MEDIAL TEMPORAL LOBE ATROPHY SCORE; MORBIDITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUROPSYCHOLOGICAL TEST; NOMINAL SKILL; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCEPTION; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SKILL; TRANSIENT ISCHEMIC ATTACK; VALIDATION STUDY; VELOCITY; VERBAL MEMORY; WHITE MATTER HYPERINTENSITY; ATROPHY; COGNITION DISORDERS; HOSPITALIZATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL; STROKE; TEMPORAL LOBE;

ATROPHY; BRAIN ISCHEMIA; COGNITION DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TEMPORAL LOBE;

EID: 84938206274     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12544     Document Type: Article

References (42)

1. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4:752-759.
2. Pohjasvaara T, Erkinjuntti T, Vataja R, Kaste M. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke 1997; 28:785-792.
3. Gorelick PB, Scuteri A, Black SE etal. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:2672-2713.
4. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; 69:2197-2204.
5. MRC-CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001; 357:169-175.
6. Heyman A, Fillenbaum GG, Welsh-Bohmer KA etal. Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1998; 51:159-162.
7. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999; 13(Suppl. 3):S115-123.
8. Etiene D, Kraft J, Ganju N etal. Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. J Alzheimers Dis 1998; 1:119-134.
9. Smith EE, Greenberg SM. Beta-amyloid, blood vessels, and brain function. Stroke 2009; 40:2601-2606.
10. Hulette C, Nochlin D, McKeel D etal. Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology 1997; 48:668-672.
11. Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol 2009; 5:649-658.
12. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 2010; 6:67-77.
13. Scheltens P, van der Pol L. Impact commentaries. Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 2012; 83:1038-1040.
14. Scheltens P, Leys D, Barkhof F etal. Atrophy of medial temporal lobes on MRI in 'probable' Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992; 55:967-972.
15. Kril JJ, Patel S, Harding AJ, Halliday GM. Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss. J Neurol Neurosurg Psychiatry 2002; 72:747-751.
16. Bastos-Leite AJ, van der Flier WM, van Straaten EC, Staekenborg SS, Scheltens P, Barkhof F. The contribution of medial temporal lobe atrophy and vascular pathology to cognitive impairment in vascular dementia. Stroke 2007; 38:3182-3185.
17. Du AT, Schuff N, Laakso MP etal. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus. Neurology 2002; 58:1635-1641.
18. O'Sullivan M, Ngo E, Viswanathan A etal. Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging 2009; 30:890-897.
19. Adams HP Jr, Bendixen BH, Kappelle LJ etal. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24:35-41.
20. Werring DJ, Frazer DW, Coward LJ etal. Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI. Brain 2004; 127(Pt 10):2265-2275.
21. Gavrilescu T, Kase CS. Clinical stroke syndromes: clinical-anatomical correlations. Cerebrovasc Brain Metab Rev 1995; 7:218-239.
22. Potter GM, Doubal FN, Jackson CA etal. Counting cavitating lacunes underestimates the burden of lacunar infarction. Stroke 2010; 41:267-272.
23. Wahlund LO, Barkhof F, Fazekas F etal. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32:1318-1322.
24. Gregoire SM, Chaudhary UJ, Brown MM etal. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009; 73:1759-1766.
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
26. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007; 4:e296.
27. Henon H, Pasquier F, Durieu I, Pruvo JP, Leys D. Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry 1998; 65:641-647.
28. Cordoliani-Mackowiak MA, Henon H, Pruvo JP, Pasquier F, Leys D. Poststroke dementia: influence of hippocampal atrophy. Arch Neurol 2003; 60:585-590.
29. Jokinen H, Kalska H, Ylikoski R etal. Medial temporal lobe atrophy and memory deficits in elderly stroke patients. Eur J Neurol 2004; 11:825-832.
30. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010; 120:287-296.
31. O'Brien JT, Desmond P, Ames D, Schweitzer I, Tress B. Magnetic resonance imaging correlates of memory impairment in the healthy elderly: association with medial temporal lobe atrophy but not white matter lesions. Int J Geriatr Psychiatry 1997; 12:369-374.
32. Mizuno K, Wakai M, Takeda A, Sobue G. Medial temporal atrophy and memory impairment in early stage of Alzheimer's disease: an MRI volumetric and memory assessment study. J Neurol Sci 2000; 173:18-24.
33. Mori E, Yoneda Y, Yamashita H, Hirono N, Ikeda M, Yamadori A. Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study. J Neurol Neurosurg Psychiatry 1997; 63:214-221.
34. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8:1006-1018.
35. Aggarwal NT, Decarli C. Vascular dementia: emerging trends. Semin Neurol 2007; 27:66-77.
36. Roman GC, Salloway S, Black SE etal. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke 2010; 41:1213-1221.
37. Ally BA, Gold CA, Budson AE. The picture superiority effect in patients with Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2009; 47:595-598.
38. Epelbaum S, Benisty S, Reyes S etal. Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL. Neurobiol Aging 2011; 32:2172-2182.
39. Henderson VW, Mack W, Freed DM, Kempler D, Andersen ES. Naming consistency in Alzheimer's disease. Brain Lang 1990; 39:530-538.
40. Appel J, Potter E, Bhatia N etal. Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol 2009; 30:1870-1876.
41. Nordberg A, Rinne JO, Kadir A, Langstrom B. The use of PET in Alzheimer disease. Nat Rev Neurol 2010; 6:78-87.
42. Charidimou A, Gang Q, Werring DJ. Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum. J Neurol Neurosurg Psychiatry 2012; 83:124-137.